KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Evolent Health (EVH) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Evolent Health (EVH) over the last 10 years, with Q2 2023 value amounting to $113.1 million.

  • Evolent Health's Shares Outstanding rose 2337.63% to $113.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $113.1 million, marking a year-over-year increase of 2337.63%. This contributed to the annual value of $101.5 million for FY2022, which is 1183.57% up from last year.
  • Latest data reveals that Evolent Health reported Shares Outstanding of $113.1 million as of Q2 2023, which was up 2337.63% from $112.6 million recorded in Q1 2023.
  • Evolent Health's 5-year Shares Outstanding high stood at $113.1 million for Q2 2023, and its period low was $79.4 million during Q1 2019.
  • For the 5-year period, Evolent Health's Shares Outstanding averaged around $91.0 million, with its median value being $87.0 million (2021).
  • As far as peak fluctuations go, Evolent Health's Shares Outstanding surged by 154.39% in 2020, and later surged by 2337.63% in 2023.
  • Over the past 5 years, Evolent Health's Shares Outstanding (Quarter) stood at $84.6 million in 2019, then increased by 1.54% to $85.9 million in 2020, then increased by 5.66% to $90.8 million in 2021, then rose by 11.84% to $101.5 million in 2022, then rose by 11.41% to $113.1 million in 2023.
  • Its Shares Outstanding stands at $113.1 million for Q2 2023, versus $112.6 million for Q1 2023 and $101.5 million for Q4 2022.